New Vernon Capital Holdings Ii LLC Harmony Biosciences Holdings, Inc. Transaction History
New Vernon Capital Holdings Ii LLC
- $4.38 Billion
- Q1 2025
A detailed history of New Vernon Capital Holdings Ii LLC transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, New Vernon Capital Holdings Ii LLC holds 488,424 shares of HRMY stock, worth $15.6 Million. This represents 0.34% of its overall portfolio holdings.
Number of Shares
488,424
Previous 14,716
3219.0%
Holding current value
$15.6 Million
Previous $506,000
2808.3%
% of portfolio
0.34%
Previous 0.3%
Shares
3 transactions
Others Institutions Holding HRMY
# of Institutions
278Shares Held
44.8MCall Options Held
130KPut Options Held
46.5K-
Valor Management LLC Chicago, IL6.62MShares$211 Million91.68% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$186 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.7MShares$150 Million0.0% of portfolio
-
State Street Corp Boston, MA1.58MShares$50.3 Million0.0% of portfolio
-
American Century Companies Inc Kansas City, MO1.29MShares$41.1 Million0.03% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $1.88B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...